银覆盖冠状硅柱阵列基底的制备、SERS特性分析及肿瘤标志物miRNA-106a的检测

以聚苯乙烯(PS)小球为模板,采用金属辅助刻蚀和湿法化学刻蚀技术,制备大面积冠状硅柱阵列,再原位生长银纳米粒子后得到银覆盖冠状硅柱阵列(Ag/Si CPA)基底。实验表明,制备的基底具有优良的表面增强拉曼散射(SERS)特性,电磁增强因子达到1.81×10~6。同时,将制备的罗丹明分子(R6G)标记的DNA发卡探针与基底链接,在与miRNA-106a互补杂交后进行SERS信号检测,获得相应的剂量-响应曲线。结果表明,基于(Ag/Si CPA)基底的SERS特性,开展miRNA-106a的检测,具有特异性好和灵敏度高的优势,检测范围为1 fmol·L~(-1)～100 pmol·L~(-1),检测极限为0.917 fmol·L~(-1)。此外,与实时荧光定量多聚核苷酸链式反应(RT-qPCR)方法相比,不仅检测结果一致,而且基于SERS光谱技术的检测方法具有更高的灵敏度。     

Tumor‐Targeting W18O49 Nanoparticles for Dual‐Modality Imaging and Guided Heat‐Shock‐Response‐Inhibited Photothermal Therapy in Gastric Cancer

Photothermal therapy (PTT) is an emerging noninvasive and precise localized therapeutic modality; however, it is deeply limited by its poor tumor accumulation, inadequate photothermal conversion efficiency, and the thermoresistance of cancer cells. Aimed at these shortcomings, tumor‐targeting nanoparticles (iRGD‐W₁₈O₄₉‐17AAG) comprising carboxyl‐group‐functionalized W₁₈O₄₉ nanoparticles, integrin‐targeting peptide iRGD, and HSP90‐inhibitor 17AAG are developed. The W₁₈O₄₉ nanoparticles act as excellent PTT carriers and computed tomography (CT) imaging contrast agents. The ring type polypeptide iRGD promotes the accumulation of nanoparticles in the tumour and further penetration into cancer cells. The introduction of 17AAG can inhibit the heat‐shock response and overcome the thermoresistance, thus increasing the curative effect of PTT and reducing the chance of tumor recurrence. The W₁₈O₄₉ nanoparticles can also be used to monitor and guide the phototherapeutic through CT and near‐infrared fluorescence imaging after modification with Cy5.5. In addition, superior biosafety is also indicated in both preliminary in vitro and in vivo assessments. The potential of iRGD‐W₁₈O₄₉‐17AAG in tumor targeting, dual modality imaging‐guided and remarkable enhanced PTT of gastric cancer with ignorable side effect both in vitro and in vivo, which may be further applied in clinic, is highlighted.     

Extinction Effects of Multiplicative Non-Gaussian L′evy Noise in a Tumor Growth System with Immunization

The extinction phenomenon induced by multiplicative non-Gaussian Levy noise in a tumor growth model with immune response is discussed. Under the influence of the stochastic immune rate, the model is analyzed in terms of a stochastic differential equation with multiplicative noise. By means of the theory of the infinitesimal generator of Hunt processes, the escape probability, which is used to measure the noise-induced extinction probability of tumor cells, is explicitly expressed as a function of initial tumor cell density, stability index and noise intensity. Based on the numerical calculations, it is found that for different initial densities of tumor cells, noise parameters play opposite roles on the escape probability. The optimally selected values of the multiplicative noise intensity and the stability index are found to maximize the escape probability.     

基于Faster-RCNN和Level-Set的桥小脑角区肿瘤自动精准分割

桥小脑角区（CPA）肿瘤的精准分割在手术治疗、放疗中有重要影响,本文结合更快速区域卷积神经网络（Faster-RCNN）和水平集（Level-Set）方法对CPA肿瘤的自动分割进行了研究.首先,采集317名CPA肿瘤患者的T₁WI-SE序列磁共振图像,使用基于Faster-RCNN主干网络VGG16提取特征,结合区域建议网络（RPN）进行学习训练,建立带有CPA肿瘤位置信息的定位模型,再应用Level-Set对肿瘤进行精准分割.本文对比了不同CPA肿瘤区域勾画范围对分割结果产生的影响,并以精确率、召回率、均值平均精度值（mAP）和戴斯系数（Dice系数）等指标评估了模型定位和分割的性能.实验结果表明,结合Faster-RCNN和Level-Set建立的模型能更有效对CPA肿瘤进行精准分割,减轻临床医生的负担,并提升治疗效果.     

噻胺酮麻醉剂对鼠S180肿瘤31P MRS的影响

对实验动物肿瘤进行活体³¹P MRS研究首要的是有效地固定动物.本文初步研究了用噻胺酮麻醉后的小鼠S180肿瘤在麻醉过程中³¹P MRS随时间的变异性.研究发现噻胺酮是一个安全系数高、起效快、麻醉过程适宜且对肿瘤的³¹P MRS无显著影响的麻醉药.因而噻胺酮适用于连续测定³¹P MRS的需要.     

OXIRIS project: Development of a new XRF device for the simultaneous detection and treatment of cancer

A novel and suitable energy-dispersive X-ray fluorescent (EDXRF) device, currently at the prototype stage, the Project OXIRIS (Orthovoltage X-Ray–Induced Radiation System), is presented for the simultaneous detection and treatment of cancer diseases. Monte Carlo simulation and experimental results of EDXRF signals from a small deep artificial tumor consisting of a solution of gold nanoparticles bio-targeted and immersed in a tissue-bioequivalent matrix are presented and compared. Briefly, the device consists of a dynamic orthovoltage X-ray fluence concentration coupled to confocal with an EDXRF system along with a sample holder for 3D scanning; all integrated and controlled by a dedicated software capable of controlling the whole operation functionalities: the X-ray source, the rotating arm, the sample holder, and the detection system. The software also includes dedicated subroutines for X-ray fluorescent spectra processing to correlate K-lines signal at each acquisition position with the corresponding high atomic number elements' concentration to produce a 3D distribution according to the user-defined grid. The confocal configuration ensures that the detected signal comes exclusively from the excited volume as defined by the bulk of the focal spot. Hence, the 3D image is achieved by scanning the sample holder through the movement of the sample-carrier stretcher moved by step motors in the 3 coordinated axes. The feasibility of the proposed methodology and the design of the prototype have been successfully demonstrated experimentally, targeting gold nanoparticles in water-equivalent phantoms.     

Tumor Hypoxia Heterogeneity Affects Radiotherapy: Inverse-Percolation Shell-Model Monte Carlo Simulations

Tumor hypoxia was discovered a century ago, and the interference of hypoxia with all radiotherapies is well known. Here, we demonstrate the potentially extreme effects of hypoxia heterogeneity on radiotherapy and combination radiochemotherapy. We observe that there is a decrease in hypoxia from tumor periphery to tumor center, due to oxygen diffusion, resulting in a gradient of radiative cell-kill probability, mathematically expressed as a probability gradient of occupied space removal. The radiotherapy-induced break-up of the tumor/TME network is modeled by the physics model of inverse percolation in a shell-like medium, using Monte Carlo simulations. The different shells now have different probabilities of space removal, spanning from higher probability in the periphery to lower probability in the center of the tumor. Mathematical results regarding the variability of the critical percolation concentration show an increase in the critical threshold with the applied increase in the probability of space removal. Such an observation will have an important medical implication: a much larger than expected radiation dose is needed for a tumor breakup enabling successful follow-up chemotherapy. Information on the TME’s hypoxia heterogeneity, as shown here with the numerical percolation model, may enable personalized precision radiation oncology therapy.     

中红外光纤技术用于口腔肿瘤在体原位检测的研究

肿瘤是严重威胁人类健康和生命的疾病,早期诊断和及时治疗是提高肿瘤病人存活率的重要因素,肿瘤的发生和发展一般可分为3个阶段：(1)基因突变;(2)生物分子组成和结构发生改变;(3)细胞和组织形态发生变化,目前常用的影像学方法只能检测较大的肿块,组织标本的病理诊断法需在     

Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment

Immunomodulation of the tumor microenvironment is emerging as an important area of research for the treatment of cancer patients. Several synthetic and natural agents are being investigated for their ability to enhance the immunogenic responses of immune cells present in the tumor microenvironment to impede tumor cell growth and dissemination. Among them, resveratrol, a stilbenoid found in red grapes and many other natural sources, has been studied extensively. Importantly, resveratrol has been shown to possess activity against various human diseases, including cancer. Mechanistically, resveratrol has been shown to regulate an array of signaling pathways and processes involving oxidative stress, inflammation, apoptosis, and several anticancer effects. Furthermore, recent research suggests that resveratrol can regulate various cellular signaling events including immune cell regulation, cytokines/chemokines secretion, and the expression of several other immune-related genes. In this review, we have summarized recent findings on resveratrol’s effects on immune regulatory cells and associated signaling in various cancer types. Numerous immunomodulatory effects of resveratrol suggest it may be useful in combination with other cancer therapies including immunotherapy for effective cancer management.